Hazardous Disposal — Apply federal requirements for handling and disposal of hazardous and non-hazardous substances - Pharmacy Technician Certification Exam Ptce

SECTION 1

Historical Context & Motivation

Before the 1970s, healthcare facilities in the United States operated with minimal regulation regarding the disposal of pharmaceutical waste. Hospitals, pharmacies, and clinics routinely discarded unused medications, contaminated materials, and chemical byproducts into municipal waste streams or down sink drains, with little understanding of the downstream environmental and public health consequences. Groundwater contamination events, toxic landfill leachate, and community health crises eventually forced the federal government to establish comprehensive regulatory frameworks. The emergence of the modern hazardous waste management system was shaped by several landmark legislative actions and environmental disasters that brought pharmaceutical waste into the regulatory spotlight.

1970 • EPA Established

The Environmental Protection Agency (EPA) was created under the Nixon administration to consolidate federal environmental research, monitoring, and enforcement into a single agency, establishing the foundation for all subsequent hazardous waste regulation.

1976 • RCRA Enacted

The Resource Conservation and Recovery Act (RCRA) established the 'cradle-to-grave' framework for managing hazardous waste, including generation, transportation, treatment, storage, and disposal requirements under 40 CFR Parts 260–265.

1980 • CERCLA (Superfund)

The Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) authorized cleanup of contaminated sites and established liability for parties responsible for hazardous substance releases, including pharmaceutical manufacturers and healthcare facilities.

2008 • EPA Targets Pharmaceuticals

The EPA began specifically addressing pharmaceutical waste contamination in waterways, leading to initiatives that culminated in a dedicated regulatory framework distinguishing pharmaceutical waste from general chemical hazardous waste.

2019 • 40 CFR Part 266 Subpart P

The EPA finalized regulations under 40 CFR Part 266, Subpart P, creating specific management standards for hazardous waste pharmaceuticals, replacing the previous patchwork of general RCRA rules applied to healthcare settings.

These regulatory milestones reflect the central question that this lesson addresses: How do federal requirements classify, handle, and mandate the disposal of hazardous and non-hazardous substances encountered in pharmacy practice? For pharmacy technicians, mastery of these requirements is not merely academic — it is a daily operational reality and a core competency tested on the PTCE.

SECTION 2

Core Principles & Definitions

Federal hazardous waste regulation in pharmacy practice rests on several foundational concepts that distinguish different categories of waste, assign generator responsibilities, and dictate appropriate disposal pathways. Understanding these principles is essential because the consequences of non-compliance range from substantial financial penalties to criminal prosecution. The EPA, OSHA, and the DEA each contribute distinct but overlapping requirements that pharmacy technicians must navigate simultaneously.

Hazardous Waste (RCRA)

Waste that exhibits one or more of four characteristics — ignitability, corrosivity, reactivity, or toxicity (D-list) — or appears on one of the EPA's four hazardous waste lists: F-list (non-specific source), K-list (specific source), P-list (acutely hazardous), and U-list (toxic).

P-List vs. U-List Drugs

P-listed pharmaceuticals are acutely hazardous (e.g., epinephrine, warfarin ≥0.3%, nicotine, phentermine). U-listed pharmaceuticals are toxic but not acutely so (e.g., cyclophosphamide, lindane, mercury-containing compounds). The distinction dictates generator status thresholds.

Cradle-to-Grave Accountability

RCRA requires that the generator of hazardous waste maintains responsibility from the point of generation through transportation, treatment, storage, and final disposal. Generators use EPA ID numbers, manifest forms, and keep records for a minimum of three years.

Non-Hazardous Pharmaceutical Waste

Pharmaceuticals not on the P or U lists and not exhibiting RCRA characteristics are classified as non-hazardous pharmaceutical waste. These still cannot be disposed of in regular trash or sewer systems and must be managed through approved disposal programs, typically incineration at permitted facilities.

Generator Categories

EPA classifies generators as Large Quantity Generators (LQG) producing ≥1,000 kg/month, Small Quantity Generators (SQG) producing 100–999 kg/month, or Very Small Quantity Generators (VSQG) producing <100 kg/month. For P-listed (acutely hazardous) waste, the threshold drops to just 1 kg/month.

✦

KEY TAKEAWAY

Think of hazardous waste classification like airport security screening. Every item (pharmaceutical) must pass through the checkpoint: first, is it on the 'no-fly list' (P-list or U-list)? If not, does it exhibit suspicious characteristics (ignitability, corrosivity, reactivity, toxicity)? If it clears both checks, it's non-hazardous but still not free to roam — it must follow an approved route to its destination. The P-list designation triggers the strictest handling, just as a flagged passenger triggers the highest-level response.

SECTION 3

Visual Explanation — Waste Classification Decision Flowchart

This decision flowchart illustrates the sequential classification process for pharmaceutical waste. Each waste item is first checked against the P-list (acutely hazardous), then the U-list (toxic), then tested for D-code characteristics (ignitability, corrosivity, reactivity, toxicity), and finally screened for DEA controlled substance status. Substances clearing all checks are classified as non-hazardous pharmaceutical waste.

The flowchart above represents the practical decision-making process that pharmacy technicians must apply whenever pharmaceutical waste is generated. The order of evaluation matters: a medication like warfarin in a concentration of 0.3% or greater is identified at the very first decision point as a P-listed acutely hazardous substance (P001), which triggers the most stringent handling requirements including the 1 kg/month generator threshold. In contrast, cyclophosphamide passes the P-list check but is captured at the U-list stage (U058), subjecting it to standard RCRA hazardous waste management protocols. A substance like outdated hydrogen peroxide in high concentration might not appear on either list but would be flagged at the characteristics stage for reactivity (D003) or ignitability (D001). This systematic approach ensures that no pharmaceutical waste stream is overlooked.

SECTION 4

How Federal Requirements Work — Regulatory Mechanisms

The RCRA Framework: Cradle-to-Grave Tracking

The Resource Conservation and Recovery Act (RCRA) mandates a comprehensive tracking system for hazardous waste from the moment it is generated until its final disposal. This system relies on three interconnected mechanisms: generator identification via EPA ID numbers, manifest documentation using EPA Form 8700-22 (the Uniform Hazardous Waste Manifest), and recordkeeping obligations requiring a minimum three-year retention period. Under 40 CFR Part 266 Subpart P, healthcare facilities that are classified as healthcare facilities eligible for the pharmaceutical-specific provisions can use an alternative streamlined system rather than full RCRA generator requirements, provided they comply with all conditions of the subpart.

Container and Labeling Requirements

Hazardous pharmaceutical waste must be collected in containers that are compatible with the waste being stored, structurally sound, and clearly labeled. Under Subpart P, containers at the point of generation in a healthcare facility must be labeled with the words "Hazardous Waste Pharmaceuticals" and remain closed when not actively receiving waste. Non-hazardous pharmaceutical waste containers must also be segregated and labeled to prevent commingling with hazardous streams. The practice of color-coded waste containers — black for RCRA hazardous waste, blue for non-hazardous pharmaceutical waste, and yellow for chemotherapy/cytotoxic trace waste — while not universally mandated by EPA, is an industry best practice widely adopted in compliance with OSHA and Joint Commission standards.

The Sewer Ban and Drain Disposal Prohibition

One of the most consequential provisions of the 2019 Subpart P regulations is the sewer ban, which explicitly prohibits healthcare facilities from disposing of hazardous waste pharmaceuticals down the drain or into sewer systems. Prior to this rule, many facilities routinely flushed certain medications, particularly liquid formulations, as a convenient disposal method. The sewer ban extends to all hazardous waste pharmaceuticals and applies regardless of the volume being disposed. For non-hazardous pharmaceuticals, the EPA defers to local publicly owned treatment works (POTW) regulations, but many states have adopted parallel bans. This prohibition represents a significant operational shift for pharmacies and requires the establishment of alternative collection and disposal pathways.

OSHA and Hazardous Drug Handling

While RCRA governs waste disposal, the Occupational Safety and Health Administration (OSHA) regulates worker safety during handling. OSHA requires employers to maintain Safety Data Sheets (SDS) for all hazardous chemicals in the workplace under the Hazard Communication Standard (29 CFR 1910.1200). Pharmacy technicians must be trained on proper use of personal protective equipment (PPE), spill cleanup procedures, and exposure response protocols. The NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings provides additional guidance on which drugs require special handling precautions, including closed-system transfer devices (CSTDs) and biological safety cabinets (BSCs) for preparation.

SECTION 5

Detailed Waste Classification & Common Pharmacy Examples

This four-quadrant diagram organizes pharmaceutical waste into the four primary regulatory categories. Note that P-listed waste has significantly lower quantity thresholds than U-listed waste. The D-code characteristic waste is identified through physical/chemical testing rather than listing, and non-hazardous pharmaceutical waste still requires proper disposal through approved pathways — it is never acceptable to discard it in regular trash.

Waste Category	EPA Regulatory Basis	VSQG Threshold	Container Color (Industry Standard)
P-List (Acute)	40 CFR 261.33(e)	≤1 kg/month	Black
U-List (Toxic)	40 CFR 261.33(f)	≤100 kg/month	Black
D-Code (Characteristic)	40 CFR 261.21–261.24	≤100 kg/month	Black
Non-Hazardous Pharma	40 CFR 266 Subpart P	N/A (not RCRA hazardous)	Blue
Chemotherapy Trace	OSHA / State regs	Varies by state	Yellow
DEA Controlled Substances	21 CFR 1317	Any quantity	Per facility policy

Summary of pharmaceutical waste categories, regulatory bases, generator thresholds, and common container color coding.

⚠

PTCE Focus: The P-List Trap

A common PTCE question involves the P-list threshold. Remember: a healthcare facility generating even small amounts of P-listed acutely hazardous waste exceeding 1 kg in any calendar month is immediately elevated to SQG or LQG status, even if all other hazardous waste quantities remain below the VSQG threshold. This single provision catches many test-takers off guard because the total quantity of P-listed waste seems trivially small compared to standard RCRA thresholds.

SECTION 6

Worked Example — Classifying and Disposing of Pharmacy Waste

A hospital pharmacy has accumulated the following waste items during a routine monthly inventory clean-out: 500 mL of expired epinephrine injection (1:1000), 2 kg of expired cyclophosphamide tablets, 800 mL of an isopropyl alcohol–based compounding solvent, 15 bottles of expired amoxicillin suspension, and 50 tablets of expired hydrocodone/acetaminophen. Determine the proper classification and disposal pathway for each item.

Hospital Pharmacy Waste Classification

1
Step 1 — Classify the Epinephrine

Epinephrine is listed as P042 on the EPA's P-list, making it an acutely hazardous pharmaceutical. It must be placed in a black RCRA hazardous waste container labeled "Hazardous Waste Pharmaceuticals." The entire container and any residue are considered P-listed waste. Because the P-list threshold is only 1 kg/month, even this relatively small quantity (approximately 0.5 kg of solution) must be tracked carefully against the monthly total.

Classification: P-listed acutely hazardous waste (P042)
2
Step 2 — Classify the Cyclophosphamide

Cyclophosphamide appears on the U-list as U058. At 2 kg, this contributes to the facility's total hazardous waste quantity under standard RCRA thresholds. It is placed in a black RCRA hazardous waste container separate from or compatible with the P-listed waste. As an antineoplastic agent, OSHA also requires chemotherapy-specific PPE (double gloving, gown, eye protection) during handling.

Classification: U-listed hazardous waste (U058)
3
Step 3 — Classify the Isopropyl Alcohol Solvent

Isopropyl alcohol has a flash point below 60°C (140°F), making it ignitable under the RCRA D-code characteristic test. It is classified as D001 (ignitable) characteristic hazardous waste. It should be placed in a compatible, tightly sealed container in the black RCRA hazardous waste stream. The quantity (0.8 L, approximately 0.6 kg) is added to the facility's monthly total for non-acute hazardous waste.

Classification: D-code characteristic hazardous waste (D001)
4
Step 4 — Classify the Amoxicillin Suspension

Amoxicillin does not appear on the P-list or U-list, and standard amoxicillin suspension does not exhibit any of the four RCRA characteristics (it is not ignitable, corrosive, reactive, or toxic by TCLP testing). It is classified as non-hazardous pharmaceutical waste. Under Subpart P, it must still be managed through an approved disposal pathway — typically reverse distribution or incineration at a permitted facility. It is placed in the blue non-hazardous pharmaceutical waste container.

Classification: Non-hazardous pharmaceutical waste
5
Step 5 — Classify the Hydrocodone/Acetaminophen

Hydrocodone is a Schedule II controlled substance regulated by the DEA under 21 CFR 1317. While it is not P-listed or U-listed, its disposal is subject to DEA destruction requirements. The facility must use a DEA-registered reverse distributor or participate in an authorized collection program. Two witnesses must be present for on-site destruction, and DEA Form 41 must be completed. The waste is segregated from both RCRA hazardous and non-hazardous pharmaceutical waste streams.

Classification: DEA controlled substance — requires reverse distribution or authorized destruction
6
Step 6 — Determine Generator Status

The facility generated approximately 0.5 kg of P-listed waste (epinephrine), 2 kg of U-listed waste, and 0.6 kg of D-code waste in this month, for a combined RCRA hazardous waste total of approximately 3.1 kg. Since the P-listed waste is below 1 kg, the acute waste alone does not trigger elevated generator status. The total non-acute hazardous waste (U-list + D-code = 2.6 kg) is well below the 100 kg VSQG threshold. Therefore, the facility maintains VSQG status for this month, provided no other hazardous waste streams push the totals above the thresholds.

Generator Status: Very Small Quantity Generator (VSQG)

SECTION 7

Compliance Strengths, Limitations & Common Violations

Aspect	Strengths of Federal Framework	Limitations / Challenges
Standardization	Uniform federal rules (Subpart P) provide a single framework for all healthcare facilities nationwide, reducing confusion from varied state regulations.	States can adopt more stringent requirements, creating a patchwork of additional obligations that facilities with multi-state operations must track separately.
Environmental Protection	Sewer ban and manifesting requirements have measurably reduced pharmaceutical contamination of waterways and groundwater since 2019.	Non-hazardous pharmaceuticals still lack robust federal disposal mandates, and compliance monitoring for small community pharmacies remains limited.
Classification System	P-list and U-list provide clear, codified identification of specific hazardous pharmaceuticals, enabling rapid classification decisions.	The lists are not exhaustive; new drug approvals may introduce substances whose waste status is ambiguous until EPA issues guidance or listing updates.
Enforcement	Significant civil and criminal penalties (up to $70,117 per violation per day under RCRA) create strong compliance incentives.	Enforcement resources are disproportionately directed at large generators; smaller pharmacies may receive less oversight, leading to inconsistent compliance.
Worker Safety	OSHA standards and the NIOSH hazardous drug list provide detailed handling protocols that reduce occupational exposure.	OSHA guidelines for hazardous drugs are recommendations, not enforceable standards; compliance is driven more by institutional policy and accreditation requirements.

Comparative analysis of the federal hazardous waste regulatory framework as applied to healthcare settings.

✦

KEY TAKEAWAY

The federal hazardous waste framework for pharmaceuticals functions like a multi-layered safety net: RCRA catches the environmental hazards, OSHA catches the occupational hazards, and the DEA catches the controlled substance diversion risks. No single regulation addresses all dimensions of pharmaceutical waste, which is why pharmacy technicians must understand the interplay among these agencies. When a drug like physostigmine is both a P-listed hazardous waste and a prescription medication, the facility must simultaneously satisfy RCRA disposal requirements and any applicable state pharmacy board disposal documentation rules.

SECTION 8

Connection to Advanced Regulatory Topics

The foundational RCRA framework covered in this lesson connects directly to several advanced regulatory topics that pharmacy technicians may encounter in specialized practice settings or on more advanced certification examinations. Understanding the basic classification and disposal principles prepares you to engage with these more complex regulatory landscapes.

Basic Concept (This Lesson)	Advanced/Related Topic
P-list and U-list classification	EPA Mixture Rule: determining waste codes when hazardous pharmaceuticals are mixed with other waste streams or diluted in IV solutions
RCRA generator categories (LQG, SQG, VSQG)	Healthcare Facility Subpart P elections: opting into pharmaceutical-specific provisions vs. remaining under standard generator regulations
Sewer ban for hazardous pharmaceuticals	Clean Water Act (CWA) pharmaceutical discharge limits and EPA's Effluent Guidelines for healthcare facilities
DEA controlled substance disposal (Form 41)	DEA take-back programs, collection receptacle registration under 21 CFR 1317 Subpart B, and reverse distribution chains
OSHA Hazard Communication and SDS	USP <800> Hazardous Drugs — Handling in Healthcare Settings: enforceable compounding standards that supplement OSHA guidance
Non-hazardous pharmaceutical waste disposal	State-level pharmaceutical stewardship programs and extended producer responsibility (EPR) laws requiring manufacturers to fund disposal

Mapping foundational concepts to advanced regulatory topics in pharmaceutical waste management.

One particularly important area of growing regulatory focus is USP General Chapter <800>, which became enforceable in December 2019. This chapter establishes standards for the receipt, storage, handling, compounding, dispensing, and disposal of hazardous drugs — a category broader than the EPA's P and U lists. While USP <800> is technically a compounding standard enforced through state boards of pharmacy rather than a federal environmental regulation, it creates disposal obligations that intersect directly with RCRA requirements. A pharmacy technician who understands the RCRA framework is well-positioned to grasp how USP <800> adds an additional layer of obligation for drugs identified by the NIOSH list as hazardous, regardless of their EPA listing status.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

Explain the difference between a P-listed pharmaceutical and a U-listed pharmaceutical under RCRA. Why does the distinction matter for a pharmacy's generator status classification?

Show answer

P-listed pharmaceuticals are classified as acutely hazardous, meaning they pose a severe, immediate threat to human health or the environment even in small quantities. U-listed pharmaceuticals are toxic but not acutely so. The practical significance lies in the generator status thresholds: a facility generating more than 1 kg of P-listed waste per month is automatically elevated from VSQG to at least SQG status, whereas the threshold for U-listed and other non-acute hazardous waste is 100 kg/month. This means that discarding even a small number of items like epinephrine vials (P042) or concentrated warfarin (P001) can trigger significantly more demanding regulatory obligations, including manifesting requirements, EPA ID registration, and shorter accumulation time limits.

Question 2: BASIC CALCULATION

A retail pharmacy disposes of the following items in January: 800 g of expired nicotine patches (P075), 45 kg of assorted expired OTC medications, and 3 kg of expired cyclophosphamide (U058). What is the facility's generator status for January? Explain your reasoning.

Show answer

First, evaluate the P-listed waste: 800 g (0.8 kg) of nicotine patches falls below the 1 kg/month threshold for acute hazardous waste. Next, evaluate total non-acute RCRA hazardous waste: the cyclophosphamide (U058) contributes 3 kg. The OTC medications are non-hazardous pharmaceutical waste and do not count toward RCRA totals. The combined non-acute hazardous waste total is 3 kg, which is below the 100 kg/month VSQG threshold. Since neither the acute threshold (1 kg) nor the non-acute threshold (100 kg) is exceeded, the facility maintains Very Small Quantity Generator (VSQG) status for January. However, the facility must still properly manage all three waste streams through their respective required disposal pathways.

Question 3: INTERMEDIATE

A hospital pharmacy technician discovers a broken bottle of isopropyl alcohol (70%, 1 L) on the compounding counter. The technician also finds 30 expired vials of epinephrine 1:1000 injection (1 mL each) and a box of 100 expired metformin 500 mg tablets. Describe the proper classification and immediate handling steps for each item, including any required PPE and container selection.

Show answer

The isopropyl alcohol is classified as D001 (ignitable) characteristic hazardous waste due to its flash point below 60°C. Immediate handling requires PPE including chemical-resistant gloves and eye protection. The spill should be cleaned using absorbent materials, and the contaminated absorbent becomes D001 hazardous waste to be placed in the black RCRA container. The epinephrine vials are P042 (P-listed acutely hazardous). The vials, any residual drug, and even the inner packaging that contacted the drug must be managed as P-listed waste in a black RCRA container. At 30 mL total volume, this likely remains below 1 kg but must be tracked against the monthly P-list total. PPE includes standard gloves. The metformin tablets are not on the P or U lists and do not exhibit RCRA characteristics, so they are classified as non-hazardous pharmaceutical waste. They should be placed in the blue non-hazardous pharmaceutical waste container for eventual incineration or reverse distribution. Standard gloves are adequate.

Question 4: APPLIED

You are the lead pharmacy technician at a long-term care facility that has been disposing of all pharmaceutical waste in a single container. During a state inspection, the inspector cites multiple violations. Identify at least four specific federal regulatory violations that could result from this practice, cite the relevant regulatory authority for each, and outline the corrective actions needed.

Show answer

Violation 1: Commingling of P-listed acutely hazardous waste with non-hazardous waste violates 40 CFR 261.33(e), because the entire mixed container may now be classified as acutely hazardous waste, potentially pushing the facility above the 1 kg/month threshold. Corrective action: establish separate black containers for RCRA hazardous waste. Violation 2: Failure to label containers with 'Hazardous Waste Pharmaceuticals' violates 40 CFR 266.502 (Subpart P container management standards). Corrective action: procure properly labeled containers and train staff on labeling requirements. Violation 3: If controlled substances (e.g., Schedule II–V medications) are mixed into the single container without DEA-compliant witnessing and documentation, this violates 21 CFR 1317, the DEA's disposal regulations. Corrective action: segregate controlled substance waste and establish a relationship with a DEA-registered reverse distributor. Violation 4: If hazardous pharmaceuticals were being drained into sinks as part of the single-container practice, this violates the sewer ban under 40 CFR 266.505. Corrective action: implement training on the sewer ban and establish alternative liquid waste collection. Additional corrective actions include obtaining an EPA ID number if not already registered, developing a written waste management plan, and conducting staff training documented per OSHA's Hazard Communication Standard (29 CFR 1910.1200).

Question 5: CRITICAL THINKING

A pharmaceutical manufacturer releases a new chemotherapy drug that is not yet listed on the EPA's P or U lists. The drug's SDS indicates a pH of 1.8 in solution, an LD₅₀ below the threshold that typically qualifies for P-listing, and the drug appears on the NIOSH Hazardous Drug List. Analyze how this drug should be classified for waste disposal purposes, which federal agencies have jurisdiction, and discuss the regulatory gap this scenario illustrates.

Show answer

Despite the absence of a P or U listing, this drug qualifies as RCRA characteristic hazardous waste under D002 (corrosive) because its pH of 1.8 is below the corrosivity threshold of pH ≤2.0 defined in 40 CFR 261.22. The EPA has jurisdiction over its waste disposal under RCRA. Simultaneously, OSHA has jurisdiction over worker exposure during handling because the drug appears on the NIOSH list, requiring compliance with hazardous drug handling precautions including PPE, CSTDs, and biological safety cabinets. USP <800>, enforced through state boards of pharmacy, adds enforceable standards for the drug's storage, handling, and disposal. This scenario illustrates a significant regulatory gap: the EPA's P and U lists are updated infrequently and may lag years behind drug approvals. A drug with acute toxicity comparable to P-listed substances is managed only under the less stringent characteristic waste pathway until EPA formally lists it. The practical implication is that healthcare facilities must independently assess new drugs against RCRA characteristics rather than relying solely on list-based classification. This also demonstrates why the NIOSH list and USP <800> serve as complementary safety frameworks that fill gaps in EPA environmental regulation.

SUMMARY

Lesson Summary

Summary

Federal hazardous waste disposal in pharmacy practice is governed by a multi-agency framework anchored by the Resource Conservation and Recovery Act (RCRA), which classifies pharmaceutical waste into P-listed acutely hazardous, U-listed toxic, D-code characteristic, and non-hazardous pharmaceutical categories. The cradle-to-grave tracking system requires generators to maintain EPA ID numbers, use uniform hazardous waste manifests (EPA Form 8700-22), and retain records for a minimum of three years. Generator status — VSQG, SQG, or LQG — is determined by monthly waste quantities, with a critically low 1 kg/month threshold for P-listed acutely hazardous waste.

Beyond RCRA, pharmacy technicians must navigate overlapping requirements from OSHA (worker protection via the Hazard Communication Standard, SDS, and PPE), the DEA (controlled substance disposal under 21 CFR 1317 using reverse distributors and Form 41), and USP <800> (hazardous drug handling standards enforced through state pharmacy boards). The 2019 sewer ban under 40 CFR Part 266 Subpart P prohibits drain disposal of hazardous waste pharmaceuticals. Proper container segregation (black for RCRA hazardous, blue for non-hazardous pharmaceutical, yellow for chemotherapy trace) and consistent labeling are essential daily practices. Mastery of this framework is both a PTCE examination requirement and a professional responsibility that protects patients, coworkers, and the environment.